Back to Archived News
NanoLogix Inc. Files Multiple International Patent Applications for BioNanoChannel™ and Hydrogen Bioreactor Technology
Wednesday, November 28, 2007
Hubbard, OH -- NanoLogix, Inc. a nano-biotechnology company announces that the company has submitted international patent applications for BioNanoChannel™ and Hydrogen Bioreactor technology protection for China, India, Brazil, and the EU (European Union). These filings are necessary prior to the anticipated global roll-out of the company's BioNanoChannel™ rapid bacteria/microorganism detection technology and also contribute to the protection of NanoLogix's ongoing Hydrogen Bioreactor development.
Chris Novak, NanoLogix Director of IP stated: "The strength and improved focus of the new foreign cases arose from significant improvements to the originally filed provisional patent applications. We at NanoLogix are very excited about the potential for enhancing the patent protection for these new technologies."
According to Bret Barnhizer, NanoLogix President and CEO, "This is a step forward for the company in its plans for technological and business development and sets the stage for one of our corporate goals of pursuing licensing opportunities for use of our products internationally. These applications aid us by ensuring that NanoLogix strengthens their control over the intellectual property rights to the technology."
About NanoLogix, Inc.
NanoLogix is a leading innovator in the research, development, and commercialization of nano-biotechnologies, applications and processes. The Company has 31 granted Patents and 36 Patents Pending for bioreactor-based Hydrogen Production, revolutionary rapid medical testing technologies, potential treatments for sepsis and cancer (via apoptosis), and bioremediation. Information on NanoLogix is available at www.nanologixinc.com.
This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Back to Archived News